Intelligent Bio Solutions Price to Sales Ratio 2020-2024 | INBS
Historical PS ratio values for Intelligent Bio Solutions (INBS) over the last 10 years. The current P/S ratio for Intelligent Bio Solutions as of December 02, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Intelligent Bio Solutions P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-29 | 1.60 | 0.74 | |
| 2024-09-30 | 1.73 | $2.15 | 0.80 |
| 2024-06-30 | 1.92 | $6.02 | 0.32 |
| 2024-03-31 | 4.22 | $19.41 | 0.22 |
| 2023-12-31 | 0.34 | $23.96 | 0.01 |
| 2023-09-30 | 1.03 | $27.87 | 0.04 |
| 2023-06-30 | 2.78 | $23.77 | 0.12 |
| 2023-03-31 | 2.90 | $9.66 | 0.30 |
| 2022-12-31 | 0.20 | $4.71 | 0.04 |
| 2022-09-30 | 0.42 | 0 | 0.00 |
| 2022-06-30 | 0.66 | 0 | 0.00 |
| 2022-03-31 | 0.78 | $37.04 | 0.02 |
| 2021-12-31 | 1.44 | $37.74 | 0.04 |
| 2021-09-30 | 2.52 | $45.63 | 0.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.007B | $0.003B |
| Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Intelligent Bio Solutions Inc., formerly known as GBS Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $94.383B | 11.71 |
| Cencora (COR) | United States | $49.567B | 18.28 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $22.150B | 0.00 |
| ICON (ICLR) | Ireland | $17.345B | 15.45 |
| Viatris (VTRS) | United States | $15.624B | 4.81 |
| Avantor (AVTR) | United States | $14.334B | 21.49 |
| Revvity (RVTY) | United States | $14.134B | 24.55 |
| CochLear (CHEOY) | Australia | $13.051B | 0.00 |
| Solventum (SOLV) | United States | $12.354B | 0.00 |
| BioMerieux (BMXMF) | France | $12.257B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.587B | 29.83 |
| Charles River Laboratories (CRL) | United States | $10.179B | 19.67 |
| Doximity (DOCS) | United States | $9.895B | 58.24 |
| HealthEquity (HQY) | United States | $8.867B | 48.12 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.980B | 32.49 |
| Life Times (LTH) | United States | $5.023B | 33.25 |
| Organon (OGN) | United States | $4.087B | 4.12 |
| Sotera Health (SHC) | United States | $3.730B | 19.95 |
| BrightSpring Health Services (BTSG) | United States | $3.361B | 71.48 |
| Surgery Partners (SGRY) | United States | $3.030B | 34.55 |
| Concentras Parent (CON) | United States | $2.779B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.417B | 0.00 |
| PACS (PACS) | United States | $2.409B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.281B | 0.00 |
| Premier (PINC) | United States | $2.201B | 11.45 |
| GeneDx Holdings (WGS) | United States | $2.153B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.063B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Progyny (PGNY) | United States | $1.326B | 26.84 |
| CareDx (CDNA) | United States | $1.316B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.285B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| Embecta (EMBC) | United States | $1.202B | 8.47 |
| AMN Healthcare Services Inc (AMN) | United States | $0.991B | 6.71 |
| Agilon Health (AGL) | United States | $0.861B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.745B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.660B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.497B | 0.00 |
| DocGo (DCGO) | United States | $0.442B | 16.65 |
| Enhabit (EHAB) | United States | $0.389B | 33.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.314B | 0.00 |
| LifeMD (LFMD) | United States | $0.285B | 0.00 |
| ModivCare (MODV) | United States | $0.268B | 14.57 |
| Sera Prognostics (SERA) | United States | $0.228B | 0.00 |
| Biodesix (BDSX) | United States | $0.209B | 0.00 |
| Nutex Health (NUTX) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| MultiPlan (MPLN) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.098B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| OncoCyte (OCX) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.038B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.019B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |